Spiracur announced it closed a $16 million round of debt financing with GE Capital. The proceeds will be used by Spiracur to launch new products into new care settings, and for further global expansion. Spiracur was advised in the transaction by Armentum Partners.
“The financing from GE Capital, Healthcare Financial Services (HFS) puts us in an excellent position to successfully execute our new product introductions and further expand our product offerings outside the United States,” said Chris Fashek, president and CEO for Spiracur. “We plan to aggressively grow our sales and marketing efforts in support of the new product launches and our increasing presence in new care settings worldwide. In addition, we will grow our investment in research and development.”
Spiracur’s SNaP System provides patients suffering from chronic or acute wounds with an advanced, non-invasive NPWT solution proven to heal wounds while allowing patients to maintain mobility. The innovative device weights 2.2 ounces and does not require batteries or electricity, resulting in completely silent treatment.
“We are enthusiastic about Spiracur’s business expansion and glad to have been able to provide our healthcare finance expertise to support the company’s commercialization efforts,” said Brett Haring, senior managing director for HFS’ life science finance business. “We will continue to focus on providing them with flexible financial solutions to help them grow in the portable and disposable NPWT market.”
Sunnyvale, CA-headquartered is a privately held medical device company focused on the development of innovative wound healing technologies.
This year has kept the equipment finance sector on its toes with a massive banking crisis, continually rising interest rates and consistent concerns about an economic recession. Equipment finance companies and their customers are continuing to deal with the pressure... read more
The recent deluge of state commercial financing disclosure laws designed to mimic consumer-style truth-in-lending statements raises interesting policy considerations as it relates to the inclusion or exclusion of equipment leasing and finance transactions.1 In particular, of all the relevant laws... read more